Rivaroxaban OK for stroke prevention in cancer patients

July 13, 2017

(HealthDay)—The safety and efficacy of rivaroxaban treatment for nonvalvular atrial fibrillation (AF) in patients with active cancer is similar to the general population, according to a study published in the July 15 issue of the American Journal of Cardiology.

Eva S. Laube, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues assessed the safety and efficacy of rivaroxaban in 163 patients with active cancer and AF treated from Jan. 1, 2014, to March 31, 2016. Outcomes were assessed from medical records.

After adjusting for competing risks, the researchers found that the estimated one-year cumulative incidence of was 1.4 percent and major bleeding was 1.2 percent. At one year, the risk of clinically relevant nonmajor bleeding leading to discontinuation of anticoagulation was 14.0 percent, while the cumulative incidence of mortality was 22.6 percent, reflecting an active cancer population. There was one death following an acute ischemic cerebrovascular insult.

"The safety and efficacy of rivaroxaban treatment for nonvalvular AF in patients with active is comparable to the results of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET-AF) study in the ," the authors write.

Explore further: Lower risk of gastrointestinal bleeding for apixaban

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Lower risk of gastrointestinal bleeding for apixaban

April 10, 2017
(HealthDay)—For patients receiving direct oral anticoagulant (DOAC) agents for non-valvular atrial fibrillation, apixaban is associated with a lower risk of gastrointestinal (GI) bleeding than rivaroxaban or dabigatran, ...

DAPT use variable in patients with A-fib at risk of stroke

August 16, 2016
(HealthDay)—For patients with atrial fibrillation at moderate to high risk of stroke, dual antiplatelet therapy (DAPT) use is variable among those undergoing percutaneous coronary intervention (PCI), according to a study ...

More GI bleeding seen in atrial fibrillation patients on rivaroxaban than warfarin

October 22, 2012
Patients with atrial fibrillation (AF) experienced more major and non-major clinically relevant GI bleeding when taking rivaroxaban than patients taking warfarin.

Low bleeding and stroke rates in AF patients given rivaroxaban for stroke prevention

September 1, 2015
Atrial fibrillation (AF) patients treated with rivaroxaban for stroke prevention have low rates of bleeding and stroke, reveals real-world data from the XANTUS study presented at ESC Congress today. The findings confirm clinical ...

Well-managed warfarin therapy associated with low risk of complications in patients with atrial fibrillation

April 20, 2016
In a study published online by JAMA Cardiology, Fredrik Björck, M.D., of Umea University, Umea, Sweden and colleagues evaluated the efficacy and safety of well-managed warfarin therapy in patients with nonvalvular atrial ...

Lower inpatient costs for dabigatran, rivaroxaban in A-fib

January 17, 2017
(HealthDay)—For patients with newly diagnosed atrial fibrillation (AF), inpatient costs are lower with dabigatran and rivaroxaban than with warfarin, according to a letter published online in the Jan. 24 issue of the Journal ...

Recommended for you

Imaging may allow safe tPA treatment of patients with unwitnessed strokes

April 25, 2018
A study led by Massachusetts General Hospital (MGH) investigators may lead to a significant expansion in the number of stroke patients who can safely be treated with intravenous tPA (tissue plasminogen activator), the "clot ...

Mice make over four times as many new heart muscle cells when they exercise, study finds

April 25, 2018
Doctors, health organizations, and the Surgeon General all agree that exercise is good for the heart—but the reasons why are still not well understood.

Heart disease may only be a matter of time for those with healthy obesity

April 24, 2018
People who are 30 pounds or more overweight may want to slim down a bit even if they don't have high blood pressure or any other heart disease risk, according to scientists at Wake Forest Baptist Medical Center.

Women at greater risk of stress-induced ischemia after heart attacks

April 24, 2018
Women who've previously experienced a heart attack have twice the risk of later myocardial ischemia provoked by mental stress when compared to men with a similar history, according to a study published in Circulation.

A wearable device intervention to increase exercise in peripheral artery disease

April 24, 2018
A home-based exercise program, consisting of wearable devices and telephone coaching, did not improve walking ability for patients with peripheral artery disease, according to a new Northwestern Medicine study.

Electric cars don't jolt implanted heart devices: study

April 24, 2018
(HealthDay)—People who have implanted devices to keep their hearts running smoothly can safely drive an electric car if they wish to do so, new research confirms.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.